Dengue Envelope-4, Insect

Dengue Virus Subtype 4 Recombinant, Insect Cells
Cat. No.
BT4057
Source
Insect cells.
Synonyms
Appearance
Sterile filtered colorless solution.
Purity
Protein is >95% pure as determined by 12.5% SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Dengue Virus Subtype 4 produced in Insect Cells is a polypeptide chain containing amino acids 280-674 and having a molecular weight of approximately 50kDa.
Dengue Envelope-4 is purified by proprietary chromatographic technique.

Product Specs

Introduction
Dengue fever is caused by four closely related virus serotypes of the genus Flavivirus, family Flaviviridae. Each serotype is distinct enough that it does not provide cross-protection, meaning a person can be infected with multiple serotypes. This can lead to more severe epidemics (hyperendemicity). Research has shown that Morpholino antisense oligos can effectively target and inhibit Dengue virus replication in cell cultures and mice models.
Description
This recombinant Dengue Virus Subtype 4 Envelope protein is produced in insect cells. It encompasses amino acids 280-674 of the protein sequence, resulting in a polypeptide with a molecular weight of approximately 50kDa. The protein is purified using a proprietary chromatographic technique to ensure high purity.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The Dengue Envelope-4 protein is supplied in a solution containing 1xD-PBS at pH 7.4, 0.1% Thimerosal (preservative), 5mM EDTA (chelating agent), and a protease inhibitor cocktail consisting of 1µg/ml each of Leupeptin, Aprotinin, and Pepstatin A.
Stability
For short-term storage (up to 4 weeks), the protein can be stored at 4°C. For long-term storage, it is recommended to store the protein at -20°C. Adding a carrier protein such as 0.1% HSA or BSA can further enhance stability during long-term storage. Avoid repeated freezing and thawing of the protein solution.
Purity
The purity of the Dengue Envelope-4 protein is greater than 95% as determined by SDS-PAGE analysis using a 12.5% gel.
Source
Insect cells.

Product Science Overview

Introduction to Dengue Virus

Dengue virus (DENV) is a mosquito-borne virus that belongs to the Flaviviridae family. It is responsible for causing dengue fever, a disease that affects millions of people worldwide, particularly in tropical and subtropical regions. The virus has four genetically distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4 . Each serotype can cause a range of symptoms from mild febrile illness to severe dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) .

Dengue Virus Subtype 4 (DENV-4)

DENV-4 is one of the four serotypes of the dengue virus. It has been associated with outbreaks in various parts of the world, including Southeast Asia, the Pacific Islands, and the Americas . The emergence of new genotypes within DENV-4 has led to increased severity of the disease in some regions . Understanding the molecular characteristics of DENV-4 is crucial for developing effective diagnostic tools and vaccines.

Recombinant Dengue Virus

Recombinant technology involves the use of genetic engineering to produce viral proteins in various host systems. This approach is widely used in the development of vaccines and diagnostic tools. Recombinant dengue virus proteins can be produced in different expression systems, including bacterial, yeast, mammalian, and insect cells .

Insect Cell Expression System

Insect cells are commonly used for the production of recombinant proteins due to their ability to perform post-translational modifications similar to those in mammalian cells. The baculovirus expression vector system (BEVS) is a popular method for producing recombinant proteins in insect cells . This system involves the use of baculovirus to infect insect cells, leading to high-level expression of the desired protein.

Production of DENV-4 Recombinant Proteins in Insect Cells

The production of DENV-4 recombinant proteins in insect cells involves several steps:

  1. Cloning of the DENV-4 gene: The gene encoding the desired DENV-4 protein is cloned into a baculovirus transfer vector.
  2. Transfection of insect cells: The recombinant baculovirus is used to transfect insect cells, such as Spodoptera frugiperda (Sf9) cells.
  3. Protein expression: The infected insect cells produce the DENV-4 protein, which can be harvested and purified for further use .
Applications of DENV-4 Recombinant Proteins

Recombinant DENV-4 proteins produced in insect cells have several applications:

  • Vaccine development: Recombinant proteins can be used as antigens in subunit vaccines. These vaccines are designed to elicit an immune response without causing disease .
  • Diagnostic tools: Recombinant proteins can be used in serological assays to detect antibodies against DENV-4 in patient samples .
  • Research: Recombinant proteins are valuable tools for studying the structure and function of viral proteins, as well as for screening antiviral compounds .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.